187 related articles for article (PubMed ID: 24176732)
1. Synthesis, in vitro and in vivo antitumor activity of symmetrical bis-Schiff base derivatives of isatin.
Liang C; Xia J; Lei D; Li X; Yao Q; Gao J
Eur J Med Chem; 2014 Mar; 74():742-50. PubMed ID: 24176732
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of bis-Schiff bases of isatins and their antiglycation activity.
Khan KM; Khan M; Ali M; Taha M; Rasheed S; Perveen S; Choudhary MI
Bioorg Med Chem; 2009 Nov; 17(22):7795-801. PubMed ID: 19837595
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and apoptosis inducing studies of triazole linked 3-benzylidene isatin derivatives.
Nagarsenkar A; Guntuku L; Guggilapu SD; K DB; Gannoju S; Naidu VGM; Bathini NB
Eur J Med Chem; 2016 Nov; 124():782-793. PubMed ID: 27639369
[TBL] [Abstract][Full Text] [Related]
4. New isatin derivatives with antioxidant activity.
Andreani A; Burnelli S; Granaiola M; Leoni A; Locatelli A; Morigi R; Rambaldi M; Varoli L; Cremonini MA; Placucci G; Cervellati R; Greco E
Eur J Med Chem; 2010 Apr; 45(4):1374-8. PubMed ID: 20060202
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of novel 1H-1,2,3-triazole tethered C-5 substituted uracil-isatin conjugates and their cytotoxic evaluation.
Kumar K; Sagar S; Esau L; Kaur M; Kumar V
Eur J Med Chem; 2012 Dec; 58():153-9. PubMed ID: 23124212
[TBL] [Abstract][Full Text] [Related]
6. Comparative Anticancer Activity and Molecular Docking of Different Isatin-Based Scaffolds.
Espinosa-Rodriguez BA; Nieto-Moreno AM; Arredondo-Espinoza EU; Avalos-Alanís FG; Balderas-Renteria I
Anticancer Res; 2021 Oct; 41(10):4969-4977. PubMed ID: 34593444
[TBL] [Abstract][Full Text] [Related]
7. In vitro cytotoxicity evaluation of some substituted isatin derivatives.
Vine KL; Locke JM; Ranson M; Benkendorff K; Pyne SG; Bremner JB
Bioorg Med Chem; 2007 Jan; 15(2):931-8. PubMed ID: 17088067
[TBL] [Abstract][Full Text] [Related]
8. Bis-isatin hydrazones with novel linkers: Synthesis and biological evaluation as cytotoxic agents.
Ibrahim HS; Abou-Seri SM; Ismail NSM; Elaasser MM; Aly MH; Abdel-Aziz HA
Eur J Med Chem; 2016 Jan; 108():415-422. PubMed ID: 26706352
[TBL] [Abstract][Full Text] [Related]
9. New Inducible Nitric Oxide Synthase and Cyclooxygenase-2 Inhibitors, Nalidixic Acid Linked to Isatin Schiff Bases via Certain l-Amino Acid Bridges.
Naglah AM; Ahmed AF; Wen ZH; Al-Omar MA; Amr Ael-G; Kalmouch A
Molecules; 2016 Apr; 21(4):498. PubMed ID: 27092477
[TBL] [Abstract][Full Text] [Related]
10. Schiff bases of indoline-2,3-dione (isatin) derivatives and nalidixic acid carbohydrazide, synthesis, antitubercular activity and pharmacophoric model building.
Aboul-Fadl T; Bin-Jubair FA; Aboul-Wafa O
Eur J Med Chem; 2010 Oct; 45(10):4578-86. PubMed ID: 20696500
[TBL] [Abstract][Full Text] [Related]
11. Anticonvulsant activity of Schiff bases of isatin derivatives.
Verma M; Pandeya SN; Singh KN; Stables JP
Acta Pharm; 2004 Mar; 54(1):49-56. PubMed ID: 15050044
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis and QSAR study of novel isatin analogues inspired Michael acceptor as potential anticancer compounds.
Wang J; Yun D; Yao J; Fu W; Huang F; Chen L; Wei T; Yu C; Xu H; Zhou X; Huang Y; Wu J; Qiu P; Li W
Eur J Med Chem; 2018 Jan; 144():493-503. PubMed ID: 29288946
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and QSAR study of certain isatin-pyridine hybrids as potential anti-proliferative agents.
Eldehna WM; Altoukhy A; Mahrous H; Abdel-Aziz HA
Eur J Med Chem; 2015 Jan; 90():684-94. PubMed ID: 25499988
[TBL] [Abstract][Full Text] [Related]
14. The Anti-Breast Cancer Potential of Bis-Isatin Scaffolds.
Guo H; Diao QP
Curr Top Med Chem; 2020; 20(16):1499-1503. PubMed ID: 32156238
[TBL] [Abstract][Full Text] [Related]
15. Diorganotin(IV) derivatives of substituted N-hydroxybenzamides with selective cytotoxicity in vitro and potent antitumor activity in vivo.
Li YL; Wang ZW; Guo P; Tang L; Ge R; Ban SR; Chai QY; Niu L; Li QS
J Inorg Biochem; 2014 Apr; 133():1-7. PubMed ID: 24413257
[TBL] [Abstract][Full Text] [Related]
16. Discovery of novel isatin-dehydroepiandrosterone conjugates as potential anticancer agents.
Ke S; Shi L; Yang Z
Bioorg Med Chem Lett; 2015 Oct; 25(20):4628-31. PubMed ID: 26320625
[TBL] [Abstract][Full Text] [Related]
17. Fe3O4 Nanoparticles Mediated Synthesis of Novel Isatin-dihydropyrimidinone Hybrid Molecules as Antioxidant and Cytotoxic Agents.
Maddela S; Makula A; Jayarambabu N
Anticancer Agents Med Chem; 2017; 17(3):456-463. PubMed ID: 27173964
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, antiproliferative activity and genotoxicity of novel anthracene-containing aminophosphonates and a new anthracene-derived Schiff base.
Kraicheva I; Tsacheva I; Vodenicharova E; Tashev E; Tosheva T; Kril A; Topashka-Ancheva M; Iliev I; Gerasimova Ts; Troev K
Bioorg Med Chem; 2012 Jan; 20(1):117-24. PubMed ID: 22142614
[TBL] [Abstract][Full Text] [Related]
19. Isatin derivatives with activity against apoptosis-resistant cancer cells.
Evdokimov NM; Magedov IV; McBrayer D; Kornienko A
Bioorg Med Chem Lett; 2016 Mar; 26(6):1558-1560. PubMed ID: 26883150
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, spectroscopic characterization and antiproliferative evaluation in vitro of novel Schiff bases related to benzimidazoles.
Hranjec M; Starčević K; Pavelić SK; Lučin P; Pavelić K; Karminski Zamola G
Eur J Med Chem; 2011 Jun; 46(6):2274-9. PubMed ID: 21439689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
